Connexion
E-mail
Mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

Accueil Zonebourse  >  Informations  >  Barons de la Bourse  >  Biographies des Barons

Les Barons de la Bourse

Toute l'infoSociétésMarchésEconomie / ForexMat. PremièresTauxBarons de la boursePro. de la financeAgendaSecteurs 
AccueilToute l'infoLes news les plus luesBiographies des Barons
Portrait de Glenn D. Steele
Age : 74
Patrimoine public : 90 486 USD
Principales sociétés : PTC Therapeutics, Inc.
Synthèse 
Dr. Glenn D. Steele, Jr. MD, is Independent Director at Cepheid, Independent Director at WellCare Health Plans, Inc., a Member at National Academy of Sciences, a Member at American College of Surgeons Oncology Group, a Member at American Society of Clinical Oncology, President & Chief Executive Officer at Geisinger Ventures, a Member at Institute of Medicine, a Member at New England Surgical Society, Chairman at xG Health Solutions, Inc., and a Member at American Surgical Association.

He is on the Board of Directors at PTC Therapeutics, Inc., Cepheid, WellCare Health Plans, Inc., Premier Plans LLC, Premier Healthcare Solutions, Inc., Bucknell University, Northeast Regional Cancer Institute, The Global Conference Institute, Healthcare Executives Network, Agency for Integrated Care Pte Ltd., and Ingenious Med, Inc.

Dr. Steele was previously employed as Chairman by Premier, Inc., Independent Director by Weis Markets, Inc., President & Chief Executive Officer by Geisinger Health System, an Advisor by Health Evolution Management Co. LLC, Chairman by American Board of Surgery, Dean by Pritzker School of Medicine, a Director-Research Committee by American Hospital Association, Inc., a Member by American Cancer Society, Inc., a Member by IMPATH, Inc., a Member by Society of Surgical Oncology, President & Chief Executive Officer by Geisinger Health System Foundation, a Professor by The University of Chicago Medical Center, a Professor by Harvard University, and Vice President-Medical Affairs by The University of Chicago.

He also served on the board at Harvard Medical Faculty Physicians, Millennium Health LLC, and Priority Healthcare Corp.

He received his undergraduate degree from Harvard College, a doctorate degree from the New York University School of Medicine, and a doctorate degree from the University of Lund.


Postes et responsabilités de Glenn D. Steele 
Nom Titre Depuis
PTC Therapeutics, Inc.
(Recherche biotechnologique et médicale)
Independent Director 2015
Geisinger Ventures President & Chief Executive Officer -
Ingenious Med, Inc. Director 2015
Synaptive Medical, Inc. Director -
Premier Healthcare Solutions, Inc. Director 2013
City of Hope (California) Director -
Northeast Regional Cancer Institute Director -
The Global Conference Institute Director -
Premier Plans LLC Director 2007
Stratus Video LLC Director -
Health Transformation Alliance Vice Chairman -
IM-Winter Holdings, Inc. Director -
Synzi LLC Director -
American Society of Clinical Oncology Member -
National Academy of Sciences Member -
American College of Surgeons Oncology Group Member -
Institute of Medicine Member -
New England Surgical Society Member -
National Academy of Medicine of United States Member -


Participations de Glenn D. Steele 
Nom Actions%Valorisation
PTC Therapeutics, Inc. (PTCT)
(Recherche biotechnologique et médicale)
1 6500,0026%90 486 USD


Glenn D. Steele: Réseau personnel 
Actualités les plus lues 
02/04THIERRY BRETON : Thierry Breton convaincu que les Européens "convergeront", écarte un "risque alimentaire"
RE
01/04ARNAUD LAGARDÈRE : Arnaud Lagardère a démissionné de ses mandats au sein de Lagardère Media News
DJ
06/04STELIOS HAJI-IOANNOU : Le fondateur d'easyJet pense que la société pourrait être à court d'argent d'ici août
DJ
06/04JEAN-DOMINIQUE SENARD : Face à la crise, Renault et Nissan veulent démontrer que l'Alliance a un avenir -WSJ
DJ
06/04ANNE RIGAIL : Paris et Amsterdam ont promis leur aide
RE
03/04PAUL HUDSON : Sanofi pourrait avoir un vaccin contre le Covid-19 au 2e trimestre 2021 -WSJ
DJ
02/04PAUL HUDSON : Sanofi peut produire des millions de doses d'hydroxycholoroquine, dit le DG
RE
02/04BERNARD CHARLÈS : Dassault Systèmes prévoit une hausse de 14% à 17% de son CA à changes constants au T1
DJ
13:27FRANÇOIS VILLEROY DE GALHAU : Des mesures monétaires plus radicales seulement si risque majeur sur l'inflation, selon Villeroy (BCE)
RE
07/04PATRICE CAINE : Thales supprime le solde de son dividende, retire ses objectifs
RE
Plus d'actualités


© 2020 People and Ownership :   
Glenn D. Steele : Connexions 



Les Barons populaires 
William Ackman Jean-paul Agon Mark Bertolini Jeff Bezos Michael Bloomberg Richard Branson Thierry Breton Warren Buffett Jean-pierre Clamadieu Tim Cook Jean-charles Decaux Clotilde Delbos Herbert Diess Jamie Dimon Jack Dorsey Sergio Ermotti Bill Gates James Gorman Jacques Gounon Ralph Hamers David Henry Carl Icahn Robert Iger Isabelle Kocher Arnaud Lagardère Jack Ma Martina Merz Elon Musk Jean-pierre Mustier Jean-charles Naouri Xavier Niel Alexander Novak Patrick Pouyanné Noel Quinn Alexandre Ricard Urs Rohner Alfred Schindler Jean-dominique Senard David Simon Masayoshi Son Carsten Spohr Friede Springer Carlos Tavares Tidjane Thiam François Villeroy De Galhau Theodor Weimer Mark Zuckerberg Luca De Meo Isabel Dos Santos
Les Barons de A à Z